What is Upstream Bio, Inc.'s net investment in lease?

Upstream Bio, Inc. (UPB) reported net investment in lease of $1.07M in Q1 2026.

How has Upstream Bio, Inc.'s net investment in lease changed year-over-year?

Upstream Bio, Inc.'s net investment in lease decreased by 35.1% year-over-year, from $1.65M to $1.07M.

What is the long-term trend for Upstream Bio, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Upstream Bio, Inc.'s net investment in lease has grown at a 433.1% compound annual growth rate (CAGR), from $43K to $1.22M.

Upstream Bio, Inc. UPB Net Investment in Lease

Net Investment in Lease at other companies

AnaptysBio, Inc.ANAB

——

Avalo TherapeuticsAVTX

——

Theravance BiopharmaTBPH

——

Cullinan Therapeutics, Inc.CGEM

——

Ethos Technologies, Inc. LIFE

——

MoonLake ImmunotherapeuticsMLTX

——

Other financials

Income statement

See full

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

See full

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

See full

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

See full

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

See full

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

See full

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Upstream Bio, Inc.'s net investment in lease?: Upstream Bio, Inc. (UPB) reported net investment in lease of $1.07M in Q1 2026.
How has Upstream Bio, Inc.'s net investment in lease changed year-over-year?: Upstream Bio, Inc.'s net investment in lease decreased by 35.1% year-over-year, from $1.65M to $1.07M.
What is the long-term trend for Upstream Bio, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Upstream Bio, Inc.'s net investment in lease has grown at a 433.1% compound annual growth rate (CAGR), from $43K to $1.22M.